Literature DB >> 8389122

Down-regulated beta-adrenoceptors in severely failing human ventricles: uniform regional distribution, but no increased internalization.

H F Pitschner1, A Droege, M Mitze, M Schlepper, O E Brodde.   

Abstract

In chronic heart failure cardiac beta-adrenoceptors are decreased. In this study we investigated whether a) in severely failing human ventricles beta-adrenoceptors are uniformly decreased or regional variations exist, and b) the beta-adrenoceptor decrease is caused by increased internalization or is a real loss in beta-adrenoceptors. For this purpose we assessed beta-adrenoceptor number and subtype distribution in a particulate fraction (mainly sarcolemmal plasma membranes) and a light vesicle fraction of right and left ventricular segments (obtained by cutting transversal rings of 2 cm from the midventricular regions) of explanted hearts from 2 patients with end-stage congestive dilated cardiomyopathy (DCM) and one patient with end-stage ischemic cardiomyopathy (ICM). In all three hearts ventricular beta-adrenoceptor number was very low (7.5-10 and 21-26 fmol/mg protein in DCM, 15-22 fmol/mg protein in ICM compared to 68-74 fmol/mg protein in non-failing ventricles). beta-Adrenoceptors were uniformly decreased over the whole ventricular region and no considerable regional variations existed. The same held true for beta 1- and beta 2-adrenoceptors. In ICM decrease in beta-adrenoceptors was due to a concomitant reduction in beta 1- and beta 2-adrenoceptors, in DCM it was mainly caused by beta 1-adrenoceptor down-regulation. In all ventricular segments investigated light vesicle beta-adrenoceptors amounted to about 5-7% of total ventricular beta-adrenoceptors, and this was not significantly different from non-failing left ventricles. We conclude that a) in severely failing human ventricles beta-adrenoceptors are evenly down-regulated and no regional variations exist, and b) the decrease in beta-adrenoceptors is not due to enhanced internalization but is a real loss of beta-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389122     DOI: 10.1007/bf00798266

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  29 in total

Review 1.  Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure.

Authors:  O E Brodde
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

2.  Selective regulation of beta 1- and beta 2-adrenoceptors in the human heart by chronic beta-adrenoceptor antagonist treatment.

Authors:  M C Michel; A Pingsmann; J J Beckeringh; H R Zerkowski; N Doetsch; O E Brodde
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

3.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Authors:  M R Bristow; R Ginsburg; V Umans; M Fowler; W Minobe; R Rasmussen; P Zera; R Menlove; P Shah; S Jamieson
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

Review 4.  Receptor-specific mechanisms of desensitization of beta-adrenergic receptor function.

Authors:  C Hertel; J P Perkins
Journal:  Mol Cell Endocrinol       Date:  1984-10       Impact factor: 4.102

5.  Reduced effects of dopexamine on force of contraction in the failing human heart despite preserved beta 2-adrenoceptor subpopulation.

Authors:  M Böhm; B Pieske; P Schnabel; R Schwinger; B Kemkes; W P Klövekorn; E Erdmann
Journal:  J Cardiovasc Pharmacol       Date:  1989-10       Impact factor: 3.105

6.  Distribution and function of human ventricular beta adrenergic receptors in congestive heart failure.

Authors:  A R Denniss; W S Colucci; P D Allen; J D Marsh
Journal:  J Mol Cell Cardiol       Date:  1989-07       Impact factor: 5.000

7.  Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy.

Authors:  M R Bristow; F L Anderson; J D Port; L Skerl; R E Hershberger; P Larrabee; J B O'Connell; D G Renlund; K Volkman; J Murray
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

8.  Intracellular distribution of adrenoceptors in the failing human myocardium.

Authors:  C J Limas; C Limas; I F Goldenberg
Journal:  Am Heart J       Date:  1989-06       Impact factor: 4.749

9.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

10.  Differential down-regulation of beta 1- and beta 2-adrenergic receptor mRNA in C6 glioma cells.

Authors:  C Hough; D M Chuang
Journal:  Biochem Biophys Res Commun       Date:  1990-07-16       Impact factor: 3.575

View more
  4 in total

Review 1.  Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure.

Authors:  X Wang; N S Dhalla
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

Review 2.  Subtype 2 and atypical angiotensin receptors in the human heart.

Authors:  V Regitz-Zagrosek; M Neuss; C Warnecke; J Holzmeister; A G Hildebrandt; E Fleck
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

Review 3.  Beta-adrenergic receptors in failing human myocardium.

Authors:  O E Brodde
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

4.  Hypertrophic cardiomyopathy: a desensitized cardiac beta-adrenergic system in the presence of normal plasma catecholamine concentrations.

Authors:  C Schumacher; H Becker; R Conrads; U Schotten; S Pott; M Kellinghaus; M Sigmund; F Schöndube; C Preusse; H D Schulte
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-04       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.